Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KYHMU
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2024110905A1 ADC2-64-1
|
|||||
| Synonyms |
WO2024110905A1 ADC2-64-1
Click to Show/Hide
|
|||||
| Organization |
BEIGENE, LTD. | BEIGENE SWITZERLAND GMBH
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.1
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
ADC2-64-1 Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||